Gene finding in the chicken genome
© Eyras et al; licensee BioMed Central Ltd. 2005
Received: 26 October 2004
Accepted: 30 May 2005
Published: 30 May 2005
Despite the continuous production of genome sequence for a number of organisms, reliable, comprehensive, and cost effective gene prediction remains problematic. This is particularly true for genomes for which there is not a large collection of known gene sequences, such as the recently published chicken genome. We used the chicken sequence to test comparative and homology-based gene-finding methods followed by experimental validation as an effective genome annotation method.
We performed experimental evaluation by RT-PCR of three different computational gene finders, Ensembl, SGP2 and TWINSCAN, applied to the chicken genome. A Venn diagram was computed and each component of it was evaluated. The results showed that de novo comparative methods can identify up to about 700 chicken genes with no previous evidence of expression, and can correctly extend about 40% of homology-based predictions at the 5' end.
De novo comparative gene prediction followed by experimental verification is effective at enhancing the annotation of the newly sequenced genomes provided by standard homology-based methods.
The draft sequence of the chicken (Gallus gallus) genome has been recently obtained and an initial analysis completed . This genome sequence will be extremely valuable for vertebrate development, avian biology, and agriculture. To reap these benefits, however, we must be able to determine with reasonable accuracy the amino acid sequences of the proteins encoded by this genome. We therefore set out to adapt three leading gene prediction systems to the chicken genome sequence and to evaluate their predictions experimentally. Some features of the chicken genome facilitate gene prediction while others hinder it. Generally, gene prediction tends to be more accurate in more compact genomes than in the large mammalian genomes [2–6]. The chicken genome is about 40% the size of the human genome, but about three times the size of the Takifugu genome [7–11]. This translates into a substantial reduction in repeats and pseudogenes. Interspersed repeats cover about 9% of the genome, far less than the 40–50% found in mammals . The small number of processed pseudogenes is beneficial to automated annotation, as this technology often misclassifies pseudogenes as functional. De novo prediction methods need full open reading frame (ORF) mRNAs to train their statistical models and homology-based methods rely on these sequences in order to predict a core set of high quality genes. However, an abundant set of chicken full-length cDNAs was not available at the start of this project, as only about 1,800 putatively full-length cDNAs and 340,000 ESTs were deposited in GenBank .
We set out to determine how well the computational methods used for annotating protein-coding genes in the mouse and rat genomes [9, 10] would perform in this avian context, where transcriptome sequencing was much less advanced and where sequence divergence may be beyond the optimal distance. An assessment of the computational methods was carried out by a large-scale experimental verification by RT-PCR. The gene prediction tools tested were Ensembl, SGP2 and TWINSCAN. Ensembl is a homology-based method, which builds gene-models using species-specific known sequences and proteins from other species aligned to the genome . SGP2 and TWINSCAN are de novo comparative gene predictors whose only inputs are the genome to be annotated and a second informant genome [3, 4, 14–16]. In this case, the informant genome selected for comparison was human. Since Ensembl relies on mapping known genes from chicken and other organisms to the chicken genome, we surmised that its prediction set would contain fewer false positives (predicted genes that are not real) and more accurate gene structures, as well as more false negatives (real genes that are not predicted) than the de novo methods. Conversely, SGP2 and TWINSCAN should be effective in detecting bona fide genes missed by the Ensembl pipeline. In particular, we were able to verify gene structures simultaneously predicted by both de novo methods about 50% of the time. In this respect, de novo comparative methods complement homology-based methods, which in general miss genes for which there is no pre-existing evidence of transcription.
To test and compare the performance of these prediction systems under the new conditions presented by the chicken genome, we tested a large number of predicted genes by RT-PCR and direct sequencing. We sampled individually from the predictions for which either one or two of the three methods agreed, and the remainder did not. We thus focused our tests on the most difficult genes to predict and on the differences between the various prediction systems. We present here the largest experimental comparison of multiple gene-prediction programs to date as well as the first to use this kind of differential design. We aimed to evaluate how de novo and homology-based gene finding methods perform in a newly sequenced genome for which a small number of gene sequences are known. In particular we have (1) evaluated the three prediction methods, (2) investigated TWINSCAN and SGP2 as possible effective methods to complement the Ensembl prediction pipeline and (3) tested the overall specificity of the Ensembl prediction set.
Results and discussion
Experimental evaluation of gene finding in chicken
Complementing homology-based gene prediction with de novo methods
distribution of intron assemblies (IAs) for each of the 7 subsets of the Venn diagram of the three prediction sets: Ensembl (E), SGP2 (S) and TWINSCAN (T) (see also Figure 1). The number of transcripts from each prediction set participating in the intron assemblies is indicated on the right.
Distribution of intron assemblies
Number of IAs
E and S and T
(S and T) not E
(E and S) not T
(T and E) not S
S not (E+T)
T not (S+E)
E not (T+S)
Experimentally verified of intron assemblies (see also Figure 1)
Experimentally verified intron assemblies
Amplimer correctly predicted
Amplimer but junction not correctly predicted
S and T and E
(S and T) not E
(E and S) not T
(T and E) not S
S not (T + E)
T not (S + E)
E not (T + S)
Considering the set of IAs unique to one prediction set (orphans), 39% of these have one single intron and 80% have 1 or 2 introns. On the other hand, after testing experimentally 96 orphans from TWINSCAN, 88 orphans from SGP2 and 30 orphans from Ensembl, we found that about 77% of the Ensembl orphans are real genes, compared to an average 18% for TWINSCAN and SGP2 (see Figure 1, see Table 2). Thus while Ensembl orphans are more likely to be real genes not predicted by the other methods, orphan de novo predictions are more likely to be false positives.
Extending homology-based gene predictions with de novo methods
Experimental verification of IAs corresponding to Ensembl 5' extensions. The extensions are separated according to whether the 5'-most Ensembl exon also existed in TWINSCAN and/or SGP2 (linked) or not (unlinked) (see Figure 3).
Experimentally verified Ensembl extensions
Amplimer correctly predicted
Amplimer but junction not correctly predicted
Separating the extensions according to whether the extra exon was predicted either by SGP2 or by TWINSCAN showed that both methods had a comparable contribution. From the 60 linked tested extensions, 46 were predicted by SGP2 with 21 (46%) RT-PCR positives, 36 were predicted by TWINSCAN with 15 (42%) positives, and 22 were predicted by both programs with 12 (54%) positives. On the other hand, from the 29 tested unlinked extensions 15 were predicted by SGP2, with 2 positives, and 17 were predicted by TWINSCAN, with 1 positive. Finally, there were 3 cases where both, SGP2 and TWINSCAN, predicted the unlinked extra exon of which one was positive.
Testing Ensembl specificity
A randomly selected set of Ensembl predictions was assayed to evaluate Ensembl's specificity. This test measured a false positive rate of 4% (see Table S5 of the supplementary material for more details). On the other hand, the tested exon-pairs for the two-way intersection sets that included Ensembl ('(E and S) not T' and '(T and E) not S') had an average false positive rate of 19% and 35%, respectively (see Figure 1). The disparity is greater with the two-way intersection set that excludes Ensembl ('(S and T) not E'), which shows a false positive rate of 53%. One explanation for this difference is the observation that most of the Ensembl predictions have exons predicted by both SGP2 and TWINSCAN. Indeed, 25,222 (89%) of the 28,416 Ensembl transcripts have at least one exon, which is also in the SGP2 and TWINSCAN sets, and 82% of these transcripts have 2 or more exons in common with both de novo methods. Thus, Ensembl predictions are most likely to fall within a triple intersection, resulting in an increased rate of true positives. Based on previous experiments , we expected the triple intersection to give a yield close to 100% positive rate. We tested 20 cases of triple intersection and found 85% positive rate (see Figure 1C). Moreover, 94% of these positive cases had the exon-intron boundaries correctly predicted (see Figure 1D).
We compared the accuracy of the human-based predictions with the accuracy of a fish-based set of predictions. We predicted genes in chicken with SGP2 and TWINSCAN using Tetraodon nigroviridis as informant genome, and found that they are less accurate than the human-based ones (see Table S7 of the supplementary material). Additionally, we found that 85% and 98% of the Tetraodon-based predictions from TWINSCAN and SGP2, respectively, overlap the corresponding human-based ones. Interestingly, 85% of the TWINSCAN orphans overlap TWINSCAN Tetraodon-based predictions, and 80% of the SGP2 orphans overlap SGP2 Tetraodon-based predictions. On the other hand, 99% of the IAs common to TWINSCAN and SGP2 but not in Ensembl, overlap TWINSCAN or SGP2 Tetraodon-based predictions.
In this paper we have evaluated how effective purely computational approaches for genome annotation can be, even in the absence of a large collection of previously known genes, by means of the largest attempt so far to experimentally compare several gene finders. After testing the accuracy of Ensembl, SGP2 and TWINSCAN on the chicken genome we have shown that de novo comparative methods followed by experimental verification remain a successful approach in the annotation of newly sequenced genomes from which little is known.
We found that approximately 50% of predictions that were in TWINSCAN and SGP2 but not in Ensembl could be experimentally verified (Figure 1). These experiments demonstrate that de novo comparative prediction methods are effective at complementing homology-based methods and confirm that a combination of methods can improve the prediction accuracy [18–22]. Moreover, in spite of the limited gene sequence data available for chicken, the combination of TWINSCAN and SGP2 achieves better accuracy than previous attempts to verify by RT-PCR computational predictions that fall outside a set of annotations [17, 23]. On the other hand, looking at the intron assemblies unique to one prediction set, the proportion of positives is largely reduced for predictions not in Ensembl. The predictions unique to one of the de novo methods show an abundance of gene models with 2 and 3 exons, which may be artefacts due to genome misassemblies. These results are in contrast with the high success rate (77%) of the predictions unique to Ensembl. This is a reasonable observation considering that the Ensembl prediction pipeline has access to genes that do not follow a 'standard' gene-grammar (e.g., unusual codon usage), but which may nevertheless be represented in the cDNA/protein databases used.
The Ensembl chicken gene set has been found to have a 96% positive rate, whereas the IAs from the two-way intersections that include Ensembl, '(E and S) not T' and '(T and E) not S', and the Ensembl orphans, have a lower positive rate, 81%, 65% and 77%, respectively, which stems from the fact that most exons predicted by Ensembl are also predicted by both SGP2 and TWINSCAN. Additionally, de novo comparative methods are useful for extending partial predictions from homology-based methods. Ensembl may generate predictions based on protein fragments or on partial homology from other species, and TWINSCAN and SGP2 predictions can add bona fide exons to the Ensembl predictions they overlap with. For the 5' end we show that 40% of the tested cases, where either TWINSCAN or SGP2 predicted at least one additional exon, were verified (Table 3). To our knowledge, this is the first time that experimental evidence is provided for extensions to homology-based models produced by de novo methods.
We observed that the subsets containing SGP2 IAs (e.g., '(S and E) not T)') have in general a higher proportion of RT-PCR positives than those containing TWINSCAN IAs (e.g., '(T and E) not S)') (Figure 1C, Table 2). There are two factors that may contribute to this difference. The first is an intrinsic difference between TWINSCAN and SGP2 – SGP2 uses TBLASTX (translated) alignments between human and chicken to reward exons overlapping aligned regions, whereas TWINSCAN uses BLASTN (nucleotide) alignments to influence the scores of exons, splice sites, and translation initiation and termination sites. Human and chicken are sufficiently diverged that translated alignments may be more sensitive, whereas nucleotide alignments fail to cover many known exons. The other factor is incidental to the way TWINSCAN was trained and run to produce the predictions tested. TWINSCAN used 525 chicken RefSeqs to estimate parameters for its probability model. This training set was probably too small to produce optimal parameter values. SGP2, on the other hand, was run with a combination of parameters estimated from the much larger set of known human genes (for its model of chicken DNA sequence) and parameters were hand tuned using the same 525 chicken genes (for its scoring of human-chicken alignments). Although a larger fraction of SGP2 predictions yielded positive experimental results, we found that TWINSCAN tends to be more accurate than SGP2 in the prediction of the intron boundaries (Figure 1D, Table 2). This difference stems from the intron model used by TWINSCAN, as opposed to SGP2, which does not model introns explicitly. TWINSCAN was re-run after completion of the experiments with an improved intron-length model, yielding a prediction set that was substantially smaller and more accurate (see Table S6) than the set tested. In spite these differences, comparing the gene predictions with a set of coding cDNAs released after the completion of these analyses, we found that all three methods have similar sensitivity (79%) (see Methods for details), hence the de novo comparative methods cover a fraction of the transcriptome similar to homology-based methods with a minimal initial amount of genome-specific expression data.
The experimentally verified IAs represent a fraction of the actual number of chicken genes that can be eventually found using our methods. If we extrapolate the proportions of experimentally verified IAs (Figure 1C) to all the generated IAs in the Venn diagram (Figure 1B) and using an average distribution of coding exons per gene from other vertebrates (Human, Mouse and Rat), we estimate a range of 14,600 to 17,500 experimentally verifiable chicken genes from our computational predictions. In this paper we only analysed intron assemblies and deliberately left out a number of chicken protein-coding intronless predictions (3,049 from SGP2, 2,727 from TWINSCAN and 1,855 from Ensembl). The triple intersection of these intronless genes contains 148 genes, which are worth investigating and for which techniques different from the ones applied here will be required.
Considering all 2-way IAs (see Table 1), one would need 11,274 RT-PCR reactions to experimentally confirm about 7,232 (64%) genes. This number of experiments compares favourably to large-scale EST projects with the added benefit of having almost no redundancy (only gene fissions and misassemblies will contribute to redundancy). The biggest drawback to EST sequencing is its large redundancy and extensive overlap. The falling cost of primers and the increased flexibility of large-scale molecular biology centers make this approach of computational prediction followed by experimental verification cost effective and scalable [5, 6]. As RT-PCR primers can be designed with appropriate linker sites such an approach could also provide a physical resource of clonable fragments. We conclude that de novo comparative gene predictions followed by experimental verification is an effective way to carry out the annotation of a newly sequenced genome for which little gene sequence information is known. In particular, as our results show, performing RT-PCR and sequencing for all the predicted novel genes, starting with those predicted by multiple de novo methods, should enhance the quality of the annotation in forthcoming eukaryote genome sequencing projects.
Generation of predictions
The initial lack of an abundant set of known chicken gene sequences forced us to adapt the methodology for training of the de novo methods and running the Ensembl gene build. The Ensembl prediction pipeline  builds gene models from known vertebrate proteins and cDNA sequences, whereas gene models based solely on ESTs are usually kept separated as ESTGenes . For the chicken genome, ESTs were combined with the standard gene build to include additional genes and transcripts. The alignments from approximately 400,000 ESTs and 24,000 full-length cDNAs [12, 25] from multiple tissues were conciliated into non-redundant transcript structures . Those predicted models that fell on non-annotated loci and those that contributed with at least two new exons in previously annotated loci were added to the protein-based gene set. Single-exons transcripts produced by the EST/cDNA-based models were rejected, as they could not be distinguished from cloning artefacts without protein evidence. For our analyses we did not include the untranslated regions that Ensembl annotates combining the cDNA/EST and protein evidence . Ensembl also annotates processed pseudogenes , which we did not consider either.
TWINSCAN was trained on 525 chicken RefSeq sequences  aligned to the chicken genomic sequence. This set is based on a set of 1266 provisional RefSeq mRNAs from GenBank (27 March 2004) March 27 filtered in the following way: The Refseq mRNA sequences were matched with the corresponding mRNAs placed on the Chicken genome assembly at UCSC. Any mRNA not placed was not considered. Additionally, sequences without an ungapped alignment between the entire CDS portion of the Refseq mRNA and the extracted unmasked genomic sequence were removed. Additionally, cases with in-frame stop codons and/or non-canonical splice sites were also removed. TWINSCAN uses nucleotide alignments and has specific models for how the alignments modify the scores of the gene signals. The BLASTN  alignments used by TWINSCAN covered 3.8% of the chicken assembly.
SGP2 training followed a hybrid approach. SGP2 was run with human parameters for the coding statistics and splice sites, whereas the score weights that reward the human-chicken homologies and penalize the lack of them were optimised using the same set of 525 Chicken RefSeqs used for the TWINSCAN training. SGP2 was then run on unsegmented chicken chromosomes using the TBLASTX  alignments with the human genomic sequence (assembly NCBI34). These alignments, which covered approximately 3% of the Chicken genome, were enriched with 391,610 extra HSPs obtained from the ungapped Exonerate  alignments of human proteins from the Ensembl predictions (release NCBI34c), the GeneId prediction set for the same human assembly and the set of vertebrate RefSeq proteins (version of April 2004). The extra alignments covered 43% of the nucleotides in TBLASTX HSPs and 5% of their sequence represented 5,840 non-redundant homology regions that had no overlap with the TBLASTX hits. These extra alignments produced a considerable improvement of the sensitivity and specificity at the gene level with respect to SGP2 predictions using only TBLASTX HSPs when tested against the Ensembl set and the aforementioned 525 RefSeqs. It also achieved a slight improvement of the sensitivity at the exon and nucleotide level.
Classification of predictions
We classified the predictions according to the Venn diagram defined by the intersections of the three sets: Ensembl (E), TWINSCAN (T) and SGP2 (S). Using the exact identity between transcripts is problematic because the exon-structures from each prediction are in general not identical. Thus we defined the intron assembly (IA) as the element of comparison. An IA is a list of exons and introns that are contiguous in a given predicted transcript. When comparing two predictions three differentiated sets are produced: the set of IAs that are identical in both transcripts, and the two sets of IAs that are present in one prediction and not in the other (see Figure 2). If the boundaries of the exons do not agree between two predictions the produced IA contains only the exonic sequence that is common to both predictions, i.e., an intersecting IA contains the sequence and exon-structure on which both predictors agree (see Figure 2). An intron assembly represents naturally the entities to be tested by RT-PCR, where an exon-pair, separated by one or more introns and by not more than about 1 Kb, is tested for amplification in cDNA tissue libraries. As each IA contains the maximal set of introns in a given genomic locus that fall in one of the different categories of the Venn diagram, we picked up one exon-pair from each IA, making sure to test different genes in each Venn diagram.
Combining the operations of set-difference 'not', set-intersection 'and', and set-union '+', we populated the Venn diagram. For instance: the subset 'E not (T+S)' was generated by first obtaining the union of T and S predictions (T+S) and then comparing the Ensembl predictions with this latter set, hence 'E not (T+S)' contains Ensembl IAs that are not in TWINSCAN or SGP2. Similarly, we obtained the subset '(S and T) not E' by first calculating the intersection of S and T, and then calculating the set-difference against E. Note that the set-difference is non-commutative, as we keep elements from one set and use the other for comparison, hence S not T ? T not S. These operations divide the subsets into three types: (1) orphan subsets, formed by those elements that are in one set but not in any of the other two, (2) the two-way intersection subsets, formed by those elements that are in two sets and not in the third one, and (3) the triple intersection, formed by those elements that are in the three sets. Figure 1B shows the number of IAs in each of the subsets (see also Table 1).
When considering the Ensembl predictions we introduced a slight modification of the operations, as one Ensembl gene may have more than one transcript (see Figure 2b). We defined the intersecting IAs as the longest non-redundant common IA between the transcripts from either prediction. That is, from all the redundant intron assemblies in an Ensembl gene that are also in a prediction from SGP2 or TWINSCAN, we took the longest one. By the concept of redundancy of two intron assemblies we mean that they have the same splicing structure or one is included in the structure of the other, allowing for mismatches in the exon edges. Likewise, for the set difference involving Ensembl predictions we took the longest IA from all the ones in an Ensembl gene that were novel with respect to the de novo prediction. The inverse case works similarly: an IA in TWINSCAN or SGP2 which is not in an Ensembl gene is the longest IA that is novel with respect to all the Ensembl transcripts in that gene.
We classified IAs according to their position relative to the predictions from the other set against which they are compared. We considered an IA to be:
Intergenic: if it falls outside the genomic extension of any of the predictions from the other set.
Bridge: if it bridges between two different predictions in the other set.
Intronic: if it extends one or more introns of the excluded prediction, i.e., the exons of the IA fall in the introns of the other prediction.
External: if it extends the 5' or 3' of the other prediction.
Finally, IAs were further classified according to whether they are complete, i.e., they represent a complete ATG-to-STOP prediction in at least one set (Figure 4). Table S2 presents the number of complete IAs from each set. TWINSCAN predictions produced more complete novel genes within introns than SGP2, whereas SGP2 predicts more complete novel genes that extend the genomic span of other genes. Furthermore, more than 70% of the complete intergenic orphan IAs from all programs have either two or three exons. Finally, analysing the triple intersection of the prediction sets we find 10,650 IAs that are common to the three sets from which 8,837 (83%) are complete. In contrast to the complete IAs predicted by only one program, 55% of those predicted by all programs have more than 3 exons.
Comparison to chicken expression data
We compared the prediction sets against 13,880 chicken cDNAs annotated as coding for protein and 4,154 cDNAs annotated as non-coding [12, 25]. We used Exonerate in ungapped mode to directly compare the nucleotide sequence of the gene predictions against the cDNA set. We considered a cDNA to be 'found' if there was an alignment with more than 90% identity over more than 60 bp. The results showed that Ensembl and SGP2 included 79% and TWINSCAN included 77% of the coding cDNAs, whereas they included a 17%, 20% and 30% of non-coding cDNAs, respectively. Additionally, we found that 8,126 (28%) SGP2 genes, 7,037 (40%) Ensembl genes and 7,728 (27%) TWINSCAN genes aligned against the coding cDNAs; whereas 838 (3%) SGP2 genes, 1,186 (7%) Ensembl genes and 722 (2.5%) TWINSCAN genes aligned against the cDNAs labelled as non-coding. The three prediction sets together found a total of 12,009 (86.5%) of coding cDNAs, with a common set of 9,597 (69%) coding cDNAs found by all three.
Primers used in the PCR reactions were designed using primer3 and filtered using ePCR. For each IA in each tested set, two exons were selected for primer placement. This selection was made ensuring that the exons selected for primer placement were of adequate length to generate likely primers, and that there was a sufficient amount of coding sequence to give an amplicon length in the desired range. Additional checks were performed in cases where one prediction method included a coding exon not suggested by the other two prediction methods in the same transcript. In those cases, the length of the tentative exons was accounted for by what exons were selected for primer placement, helping reduce failure due to primers being placed too far apart in the actual transcript to get successful amplification. All designed primers and primer pairs were filtered for mispriming using the entire chicken genome to find potential priming locations. Primers returning priming locations not overlapping coordinates of the target gene were rejected. From all passing primer pairs for a given IA, the pair giving the longest expected product in the requested range was selected for amplification. The selection of targets appearing on each plate was done completely randomly among all targets returning at least one designed primer pair passing all criteria. The primer selection parameters used for the design of Plate 1 were consistent with primer3 defaults, except: Tm range was set to (63, 65), product length range was set to (300, 600), and primer length range was set to (23, 28) with 24 being optimal. The primer selection parameters used for the design of Plates 2–5 were also consistent with primer3 defaults, except: GC content range was set to (30, 70) with 50 being optimal, Tm range was set to (59, 62), product length range was set to (150, 500), and primer length range was set to (17, 27) with 20 being optimal.
Experimental verification of predictions by RT-PCR
Multiple organs (brain, liver, heart, spleen, lung, kidney, muscle, tongue, trachea, crop, proventriculus, gizzard, gall bladder, small-intestine, pancreas, caeca, mesentery, ovary, oviduct and testis) of an adult male and two egg-laying females of the "Bleue de Hollande" strain were collected soon after sacrifice. Total RNA was prepared from frozen tissues using TRIzol Reagent (Invitrogen) according to manufacturers' instructions. The quality of all RNA samples was checked using an Agilent 2100 Bioanalyzer (Agilent Technologies) and by PCR using pairs of oligos designed in four CNGs (Conserved Non-Genic Sequences) conserved between GGA1 and HSA21 [29, 30], as indicators of possible genomic DNA contamination. Total RNA was converted to cDNA using Superscript II (Invitrogen) primed with random primers. For each tissue in the study, 5 μg of total RNA was converted to cDNA.
Predictions of chicken genes were assayed experimentally by RT-PCR as previously described and modified [9, 16, 31]. Similar amounts of 12 Gallus gallus cDNAs (brain, liver, heart, spleen, lung, kidney, muscle, proventriculus, small intestine, caeca, ovary and testis, final dilution 1000x) were mixed with JumpStart REDTaq ReadyMix (Sigma) and 4 ng/ul primers (Sigma-Genosys) with a BioMek 2000 robot (Beckman). The ten first cycles of PCR amplification were performed with a touchdown annealing temperatures decreasing from 60 to 50°C; annealing temperature of the next 30 cycles was carried out at 50°C. Amplimers were separated on "Ready to Run" precast gels (Pharmacia) and sequenced. This procedure was used to experimentally assay 456 exon-exon junctions of chicken predictions. The later are representative of each subsets of predictions found in the Venn diagram of the three sets of predictions studied, i.e., the Ensembl, TWINSCAN and SGP2 set (see Table S3, and Table S4 for the transcripts used as internal controls). The sequences of the amplified exon-exon junctions can be obtained from the web site http://genome.imim.es/~eeyras/Chicken/GeneFinding/.
We thank J.F. Abril, O. Gonzalez, C. Rossier, M. Ruedi and C. Ucla for assistance. This work was supported by grants from the Jérôme Lejeune, Childcare and Désirée and Niels Yde Foundations, the European Union, the Swiss National Science Foundation and the NCCR Frontiers in Genetics. E Eyras is funded by the Institució Catalana de Recerca I Estudis Avançats (ICREA). R Guigo's lab acknowledges support from grants from the National Plan for R&D (Spain), QLK3-CT-2002-02062 from the European Community and HG003150-01 from the National Institutes of Health. Research on gene prediction by vertebrate genome comparison in the Brent lab is supported by grant R01 HG02278 from the National Institutes of Health. This work was also supported by EMBL and the Wellcome Trust.
- International Chicken Genome Sequencing Consortium: Sequence and Comparative Analysis of the Chicken Genome provide unique perspectives on vertebrate evolution. Nature 2004, 432(7018):695–716. Erratum in: Nature 433(7027):777 10.1038/nature03154View Article
- Alexandersson MS, Cawley , Pachter L: SLAM: cross-species gene finding and alignment with a generalized pair hidden Markov model. Genome Res 2003, 13: 496–502. 10.1101/gr.424203PubMed CentralView ArticlePubMed
- Flicek PE, Keibler P, Hu I, Korf , Brent MR: Leveraging the mouse genome for gene prediction in human: From whole-genome shotgun reads to a global synteny map. Genome Res 2003, 13: 46–54. 10.1101/gr.830003PubMed CentralView ArticlePubMed
- Parra G, Agarwal P, Abril JF, Wiehe T, Fickett JW, Guigo R: Comparative Gene Prediction in Human and Mouse. Genome Res 2003, 13: 108–117. 10.1101/gr.871403PubMed CentralView ArticlePubMed
- Tenney A, Brown RH, Vaske C, Lodge JK, Doering TL, Brent MR: Gene prediction and verification in a compact genome with numerous small introns. Genome Res 2004, 14: 2330–2335. 10.1101/gr.2816704PubMed CentralView ArticlePubMed
- Wei C, Lamesch P, Arumugam M, Rosenberg J, Hu P, Brent MR, Vidal M: Closing in on the C. elegans ORFeome by Cloning TWINSCAN. Genome Res 2005, 15(4):577–82. 10.1101/gr.3329005PubMed CentralView ArticlePubMed
- International Human Genome Sequencing Consortium: Initial Sequencing and Analysis of the Human Genome. Nature 2001, 409(6822):860–921. 10.1038/35057062View Article
- Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Smith HO, Yandell M, Evans CA, Holt RA, Gocayne JD, Amanatides P, Ballew RM, Huson DH, Wortman JR, Zhang Q, Kodira CD, Zheng XH, Chen L, Skupski M, Subramanian G, Thomas PD, Zhang J, Gabor Miklos GL, Nelson C, Broder S, Clark AG, Nadeau J, McKusick VA, Zinder N, Levine AJ, Roberts RJ, Simon M, Slayman C, Hunkapiller M, Bolanos R, Delcher A, Dew I, Fasulo D, Flanigan M, Florea L, Halpern A, Hannenhalli S, Kravitz S, Levy S, Mobarry C, Reinert K, Remington K, Abu-Threideh J, Beasley E, Biddick K, Bonazzi V, Brandon R, Cargill M, Chandramouliswaran I, Charlab R, Chaturvedi K, Deng Z, Di Francesco V, Dunn P, Eilbeck K, Evangelista C, Gabrielian AE, Gan W, Ge W, Gong F, Gu Z, Guan P, Heiman TJ, Higgins ME, Ji RR, Ke Z, Ketchum KA, Lai Z, Lei Y, Li Z, Li J, Liang Y, Lin X, Lu F, Merkulov GV, Milshina N, Moore HM, Naik AK, Narayan VA, Neelam B, Nusskern D, Rusch DB, Salzberg S, Shao W, Shue B, Sun J, Wang Z, Wang A, Wang X, Wang J, Wei M, Wides R, Xiao C, Yan C, Yao A, Ye J, Zhan M, Zhang W, Zhang H, Zhao Q, Zheng L, Zhong F, Zhong W, Zhu S, Zhao S, Gilbert D, Baumhueter S, Spier G, Carter C, Cravchik A, Woodage T, Ali F, An H, Awe A, Baldwin D, Baden H, Barnstead M, Barrow I, Beeson K, Busam D, Carver A, Center A, Cheng ML, Curry L, Danaher S, Davenport L, Desilets R, Dietz S, Dodson K, Doup L, Ferriera S, Garg N, Gluecksmann A, Hart B, Haynes J, Haynes C, Heiner C, Hladun S, Hostin D, Houck J, Howland T, Ibegwam C, Johnson J, Kalush F, Kline L, Koduru S, Love A, Mann F, May D, McCawley S, McIntosh T, McMullen I, Moy M, Moy L, Murphy B, Nelson K, Pfannkoch C, Pratts E, Puri V, Qureshi H, Reardon M, Rodriguez R, Rogers YH, Romblad D, Ruhfel B, Scott R, Sitter C, Smallwood M, Stewart E, Strong R, Suh E, Thomas R, Tint NN, Tse S, Vech C, Wang G, Wetter J, Williams S, Williams M, Windsor S, Winn-Deen E, Wolfe K, Zaveri J, Zaveri K, Abril JF, Guigo R, Campbell MJ, Sjolander KV, Karlak B, Kejariwal A, Mi H, Lazareva B, Hatton T, Narechania A, Diemer K, Muruganujan A, Guo N, Sato S, Bafna V, Istrail S, Lippert R, Schwartz R, Walenz B, Yooseph S, Allen D, Basu A, Baxendale J, Blick L, Caminha M, Carnes-Stine J, Caulk P, Chiang YH, Coyne M, Dahlke C, Mays A, Dombroski M, Donnelly M, Ely D, Esparham S, Fosler C, Gire H, Glanowski S, Glasser K, Glodek A, Gorokhov M, Graham K, Gropman B, Harris M, Heil J, Henderson S, Hoover J, Jennings D, Jordan C, Jordan J, Kasha J, Kagan L, Kraft C, Levitsky A, Lewis M, Liu X, Lopez J, Ma D, Majoros W, McDaniel J, Murphy S, Newman M, Nguyen T, Nguyen N, Nodell M, Pan S, Peck J, Peterson M, Rowe W, Sanders R, Scott J, Simpson M, Smith T, Sprague A, Stockwell T, Turner R, Venter E, Wang M, Wen M, Wu D, Wu M, Xia A, Zandieh A, Zhu X: The sequence of the human genome. Science 2001, 291(5507):1304–51. Erratum in: Science 2001, 292(5523):1838 10.1126/science.1058040View ArticlePubMed
- Mouse Genome Sequence Consortium: Initial sequencing and comparative analysis of the mouse genome. Nature 2002, 420(6915):520. 10.1038/nature01262View Article
- Rat Genome Sequencing Project Consortium: Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature 2004, 428(6982):493. 10.1038/nature02426View Article
- Aparicio S, Chapman J, Stupka E, Putnam N, Chia JM, Dehal P, Christoffels A, Rash S, Hoon S, Smit A, Gelpke MD, Roach J, Oh T, Ho IY, Wong M, Detter C, Verhoef F, Predki P, Tay A, Lucas S, Richardson P, Smith SF, Clark MS, Edwards YJ, Doggett N, Zharkikh A, Tavtigian SV, Pruss D, Barnstead M, Evans C, Baden H, Powell J, Glusman G, Rowen L, Hood L, Tan YH, Elgar G, Hawkins T, Venkatesh B, Rokhsar D, Brenner S: Whole-genome shotgun assembly and analysis of the genome of Fugu rubripes. Science 2002, 297(5585):1301–10. 10.1126/science.1072104View ArticlePubMed
- Boardman PE, Sanz-Esquerro J, Overton IM, Burt DW, Bosch E, Fong WT, Tickle C, Brown WRA, Wilson SA, Hubbart SJ: A comprehensive collection of chicken cDNAs. Curr Biol 2002, 12: 1965–1969. 10.1016/S0960-9822(02)01296-4View ArticlePubMed
- Curwen V, Eyras E, Andrews DT, Clarke L, Mongin E, Searle S, Clamp M: The Ensembl Automatic Gene Annotation System. Genome Res 2001, 14(5):942. 10.1101/gr.1858004View Article
- Korf I, Flicek P, Duan D, Brent MR: Integrating Genomic Homology into Gene Structure Prediction. Bioinformatics 2001, 17(Suppl 1):140–148.View Article
- Wu JQ, Shteynberg D, Arumugam M, Gibbs RA, Brent MR: Identification of rat genes by TWINSCAN gene prediction, RT-PCR and direct sequencing. Genome Res 2004, 14: 665–671. 10.1101/gr.1959604PubMed CentralView ArticlePubMed
- Guigo R, Dermitzakis ET, Agarwal P, Ponting CP, Parra G, Reymond A, Abril JF, Keibler E, Lyle R, Ucla C, Antonarakis SE, Brent MR: Comparison of mouse and human genomes followed by experimental verification yields an estimated 1,019 additional genes. PNAS 2003, 100(3):1140–1145. 10.1073/pnas.0337561100PubMed CentralView ArticlePubMed
- Makalowska I, Sood R, Faruque MU, Hu P, Robbins CM, Eddings EM, Mestre JD, Baxevanis AD, Carpten JD: Identification of six novel genes by experimental validation of GeneMachine predicted genes. Gene 2002, 284(1–2):203–13. 10.1016/S0378-1119(01)00897-6View ArticlePubMed
- Rogic S, Ouellette BF, Mackworth AK: Improving gene recognition accuracy by combining predictions from two gene-finding programs. Bioinformatics 2002, 18(8):1034–45. 10.1093/bioinformatics/18.8.1034View ArticlePubMed
- Howe KL, Chothia T, Durbin R: GAZE: a generic framework for the integration of gene-prediction data by dynamic programming. Genome Res 2002, 12(9):1418–27. 10.1101/gr.149502PubMed CentralView ArticlePubMed
- Zhang L, Pavlovic V, Cantor CR, Kasif S: Human-Mouse Gene Identification by Comparative Evidence Integration and Evolutionary Analysis. Genome Res 2003, 13(6):1190–1202. 10.1101/gr.703903PubMed CentralView ArticlePubMed
- Yada T, Totoki Y, Takaeda Y, Sakaki Y, Takagi T: DIGIT: A Novel Gene Finding Program by Combining Gene-Finders. Proceedings of the 8th Pacific Symposium on Biocomputing (PSB 2003), Lihue, Hawaii, USA 375–387. January 3–7, 2003
- Allen JE, Pertea M, Salzberg SL: Computational gene prediction using multiple sources of evidence. Genome Res 2004, 14(1):142–8. 10.1101/gr.1562804PubMed CentralView ArticlePubMed
- Das M, Burge CB, Park E, Colinas J, Pelletier J: Assessment of the total number of human transcription units. Genomics 2001, 77(1–2):71–8. 10.1006/geno.2001.6620View ArticlePubMed
- Eyras E, Caccamo M, Curwen V, Clamp M: ESTgenes: Alternative splicing from ESTs in Ensembl. Genome Res 2004, 14(5):976. 10.1101/gr.1862204PubMed CentralView ArticlePubMed
- Hubbard SJ, Graham DV, Beattie KJ, Overton IA, McLaren SR, Croning MDR, Boardman PE, Bonfield JK, Burnside J, Davies RM, Farrel ER, Francis MD, Griffiths-Jones S, Humphray SJ, Hyland C, Scott CE, Tang H, Taylor RG, Tickle C, Brown WRA, Birney E, Rogers J, Wilson SA: Transcriptome Analysis for the Chicken Based on 19,626 Finished cDNA Sequences and 485,337 Expressed Sequence Tags. Genome Res 2005, 15(1):174–83. 10.1101/gr.3011405PubMed CentralView ArticlePubMed
- Pruitt KD, Maglott DR: RefSeq and LocusLink: NCBI gene-centered resources. Nucleic Acids Res 2001, 29(1):137–140. 10.1093/nar/29.1.137PubMed CentralView ArticlePubMed
- Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ: Basic local alignment search tool. J Mol Biol 1990, 215: 403–410. 10.1006/jmbi.1990.9999View ArticlePubMed
- Slater GS, Birney E: Automated generation of heuristics for biological sequence comparison. BMC Bioinformatics 2005, 6(1):31. 10.1186/1471-2105-6-31PubMed CentralView ArticlePubMed
- Dermitzakis ET, Reymond A, Lyle R, Scamuffa N, Ucla C, Deutsch S, Stevenson BJ, Flegel V, Bucher P, Jongeneel CV, Antonarakis SE: Numerous potentially functional but non-genic conserved sequences on human chromosome 21. Nature 2002, 420(6915):578–82. 10.1038/nature01251View ArticlePubMed
- Dermitzakis ET, Reymond A, Scamuffa N, Ucla C, Kirkness E, Rossier C, Antonarakis SE: Evolutionary discrimination of mammalian conserved non-genic sequences (CNGs). Science 2003, 302(5647):1033–5. 10.1126/science.1087047View ArticlePubMed
- Reymond A, Camargo AA, Deutsch S, Stevenson BJ, Parmigiani RB, Ucla C, Bettoni F, Rossier C, Lyle R, Guipponi M, de Souza S, Iseli C, Jongeneel CV, Bucher P, Simpson AJ, Antonarakis SE: Nineteen additional unpredicted transcripts from human chromosome 21. Genomics 2002, 79(6):824–32. 10.1006/geno.2002.6781View ArticlePubMed
- Scripts to generate intron assemblies from prediction sets:[http://genome.imim.es/~eeyras/]
- Download page for SGP2 software and predictions:[http://genome.imim.es/software/]
- Download page for TWINSCAN software and predictions:[http://genes.cs.wustl.edu/]
- Website for Ensembl predictions in chicken:[http://www.ensembl.org/Gallus_gallus/]
- Website with supplementary data:[http://genome.imim.es/~eeyras/Chicken/GeneFinding/]
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.